LunaPBC, Genetic Alliance create drug discovery platform for rare epilepsy
Health data platform LunaPBC and the Genetical Alliance partnered with the KCNT1 Foundation to launch a drug discovery program for KCNT-1 Epilepsy. The group will partner with Biogen to study the cause of the disease and develop treatments.